Evidence map›Paper›PMID 28685029›Full record

ReviewInternational journal of obesity supplements2016

Does gastric bypass surgery change body weight set point?

Z Hao, M B Mumphrey, C D Morrison, H Münzberg, J Ye, H R Berthoud

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of obesity supplements, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. History and future of leptin: Discovery, regulation and signaling.Metabolism: clinical and experimental · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Epigenetic contribution to obesity.Mammalian genome : official journal of the International Mammalian Genome Society · 2020
    Review
  8. Review
  9. Review
  10. Effects of multiple cycles of weight loss and regain on the body weight regulatory system in rats.American journal of physiology. Endocrinology and metabolism · 2019
    Article
  11. Comment on: GLP-1 and PYYSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Z HaoNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
M B MumphreyNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
C D MorrisonNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
H MünzbergNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
J YeNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
H R BerthoudNeurobiology of Nutrition and Metabolism Department, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, LA, USA.
Pennington Biomedical Research Center · USLouisiana State University System · US

Funding

Neural mechanisms controlling food intake and body weight after bariatric surgeryR01DK047348 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BERTHOUD, HANS-RUDOLF · 1994 to 2018
$5.0M
Leptin and Central Control of ThermoregulationR01DK092587 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MUENZBERG-GRUENING, HEIKE · 2012 to 2024
$3.5M
Mechanism of IKK in FFA-associated Insulin ResistanceR01DK068036 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2004 to 2013
$2.7M
Neural regulation of protein ingestionR01DK081563 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MORRISON, CHRISTOPHER D · 2010 to 2014
$1.4M
Adipose Tissue Hypoxia and Inflammation in ObesityR01DK085495 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2010 to 2013
$1.3M
Regulation of Energy Expenditure by NF-kBR56DK068036 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2009 to 2015
$296k
NIDDK NIH HHS R01 DK047348NIDDK NIH HHS R01 DK068036NIDDK NIH HHS R01 DK081563NIDDK NIH HHS R01 DK085495NIDDK NIH HHS R01 DK092587NIDDK NIH HHS R56 DK068036
6 · The paper itself

Abstract

The relatively stable body weight during adulthood is attributed to a homeostatic regulatory mechanism residing in the brain which uses feedback from the body to control energy intake and expenditure. This mechanism guarantees that if perturbed up or down by design, body weight will return to pre-perturbation levels, defined as the defended level or set point. The fact that weight re-gain is common after dieting suggests that obese subjects defend a higher level of body weight. Thus, the set point for body weight is flexible and likely determined by the complex interaction of genetic, epigenetic and environmental factors. Unlike dieting, bariatric surgery does a much better job in producing sustained suppression of food intake and body weight, and an intensive search for the underlying mechanisms has started. Although one explanation for this lasting effect of particularly Roux-en-Y gastric bypass surgery (RYGB) is simple physical restriction due to the invasive surgery, a more exciting explanation is that the surgery physiologically reprograms the body weight defense mechanism. In this non-systematic review, we present behavioral evidence from our own and other studies that defended body weight is lowered after RYGB and sleeve gastrectomy. After these surgeries, rodents return to their preferred lower body weight if over- or underfed for a period of time, and the ability to drastically increase food intake during the anabolic phase strongly argues against the physical restriction hypothesis. However, the underlying mechanisms remain obscure. Although the mechanism involves central leptin and melanocortin signaling pathways, other peripheral signals such as gut hormones and their neural effector pathways likely contribute. Future research using both targeted and non-targeted 'omics' techniques in both humans and rodents as well as modern, genetically targeted, neuronal manipulation techniques in rodents will be necessary.

Identifiers

PMID28685029
PMCPMC5485884
OpenAlexW2554399655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.